Glycopeptides and antibiotics for Gram-Positive Bacterial Infections

Glycopeptides, lipopetides and other antibiotics such as linezolid and quinupristin/dalfopristin, are exclusively used for the treatment of infections caused by Gram-Positive Bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.